VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 127 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $7,000 | -30.0% | 1,458 | 0.0% | 0.00% | – |
Q4 2020 | $10,000 | -37.5% | 1,458 | 0.0% | 0.00% | – |
Q3 2020 | $16,000 | -11.1% | 1,458 | 0.0% | 0.00% | – |
Q2 2020 | $18,000 | +38.5% | 1,458 | 0.0% | 0.00% | – |
Q1 2020 | $13,000 | -35.0% | 1,458 | 0.0% | 0.00% | – |
Q4 2019 | $20,000 | -73.3% | 1,458 | -46.9% | 0.00% | – |
Q2 2019 | $75,000 | +134.4% | 2,747 | +64.8% | 0.00% | – |
Q1 2019 | $32,000 | +113.3% | 1,667 | 0.0% | 0.00% | – |
Q4 2018 | $15,000 | -53.1% | 1,667 | 0.0% | 0.00% | – |
Q3 2018 | $32,000 | -3.0% | 1,667 | 0.0% | 0.00% | – |
Q2 2018 | $33,000 | +6.5% | 1,667 | 0.0% | 0.00% | – |
Q1 2018 | $31,000 | +10.7% | 1,667 | 0.0% | 0.00% | – |
Q4 2017 | $28,000 | – | 1,667 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
Birchview Capital, LP | 33,000 | $310,000 | 0.29% |